openPR Logo
Press release

Rotavirus Diagnostics Market : Key Trends, Research, Strategy, Applications Analysis and Growth by Forecast to 2025

02-06-2018 03:27 PM CET | Associations & Organizations

Press release from: Rotavirus Diagnostics Market

Market Research Report

Market Research Report

Researchmoz added Most up-to-date research on "Rotavirus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025" to its huge collection of research reports.

About Rotavirus Diagnostics Market
Rotavirus is a major cause of severe childhood gastroenteritis. Rotavirus, the most significant member of the Reoviridae family, is responsible for almost two million hospital admissions, around 25 million clinic visits, and more than 0.8 million deaths among children below the age of five globally each year. Rotavirus has a worldwide incidence, both in developed and developing countries; however, maximum deaths have been observed in the developing countries. It is difficult to differentiate gastroenteritis caused by rotavirus from other enteric pathogens. Hence, identification of the cause of gastroenteritis needs analysis of fecal specimens with commercially available assays. Rotaviruses are double-stranded, non-enveloped RNA viruses, which consist of 11 segments. Viral RNA is surrounded by a three-layer capsid: outer capsid, inner capsid, and core capsid. Based on antigenic protein VP6, the International Committee on Taxonomy of Viruses (ICTV) has subdivided rotaviruses into eight groups (A–H).

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1492747

Majority of human rotaviruses belong to group A. VP4 and VP7 (proteinase sensitive protein), two structural proteins of the outer capsid, determine the P and G genotypes of a virus, respectively. Genomic segment changes may occur between strains due to the segmented structure of viral RNA, resulting in large number of P and G genotypes. Epidemiological studies reported that G9P[8], G3P[8], G2P[4], and G1P[8] have been the most common genotypes causing diseases in children in the last 20 years. G12 is reported to be a recently emerged genotype. Nucleic acid amplification, cell culture, and electron microscopy tests are used in the laboratory diagnosis of rotavirus infections. ELISA, latex agglutination, and immune chromatographic are the most commonly used methods, as these are fast, do not require special technical expertise and tools, have high specificity and sensitivity, and are easy to use.

Rotarix and RotaTeq are the two oral attenuated rotavirus vaccines for rotavirus gastroenteritis. These have been used and licensed in large number of countries since 2006. Rotarix vaccine provides a high level of protection against rotavirus gastroenteritis caused by G1, G3, G4, and G9 types. However, its protection is low for G2 type. RotaTeq vaccine, which is used in three doses, provides a high level of protection against the G1–G4 and G9 types. Rotavirus vaccines are available globally; however, they have not been included in the national vaccination programs of the every country. The coverage ratio of current rotavirus vaccines for the genotypes detected is quite high. Wide availability of immunosuppressive drugs, advances in molecular diagnostic technologies, and rise in funding from government organizations and associations drive the rotavirus diagnostics market. However, high cost of vaccines is a major restraint of the global rotavirus diagnostics market.

Make an Enquiry about TOC @ https://www.researchmoz.us/rotavirus-diagnostics-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html

The global rotavirus diagnostics market can be segmented based on type of diagnostic test, end-user, and region. In terms of type of diagnostic test, the market can be classified into enzyme immunoassay, ELISA, PCR, RT-PCR, and others. Based on end-user, the global rotavirus diagnostics market can be categorized into hospitals, commercial/private labs, physician offices, and public health labs. The global rotavirus diagnostics market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Major players operating in the global rotavirus diagnostics market are GlaxoSmithKline plc, Merck & Co., Inc., Abbott Laboratories, Affymetrix, Inc., Danaher Corporation, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Cepheid, Inc., Diamedix, Inc., DiaSorin, and Eiken Chemical Co., Ltd., among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rotavirus Diagnostics Market : Key Trends, Research, Strategy, Applications Analysis and Growth by Forecast to 2025 here

News-ID: 933798 • Views: 465

More Releases for RNA

RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led